Summary: Human cerebral organoids—small, lab-grown clusters of human brain tissue—are a powerful model for studying neurodevelopmental disorders such as Angelman syndrome. Progress has been limited by the high cost and low throughput of existing electrophysiology sensors, often restricting studies to fewer than ten organoids. Researchers have overcome this barrier with a new sensor platform called CAMEO (Conformal Array for Monitoring Electrophysiology of Organoids), a low-cost, scalable solution that enables large-scale electrical recordings from cerebral organoids.
CAMEO uses flexible carbon nanotube strands arranged in a basket-like array to cradle each organoid and record faint electrical activity. By combining sensitive carbon-based electrodes with a simplified, inexpensive manufacturing approach, CAMEO makes high-throughput organoid electrophysiology practical and affordable for many labs, opening the door to broader studies of human brain development and genetic disorders.
Key Facts
- CAMEO design: Twelve flexible carbon nanotube strands are suspended in a basket shape. An organoid sits inside while the exposed ends of the strands serve as electrodes that contact its surface.
- Cost and scalability: CAMEO replaces costly materials and complex fabrication with affordable carbon nanotube components and a straightforward assembly process, enabling plug-and-play use and mass testing.
- Sensitivity to low-amplitude signals: Despite its low cost, CAMEO detects subtle electrical signals at levels comparable to expensive, industry-standard microelectrode arrays.
- Relevance to Angelman syndrome: Animal models do not fully replicate human brain development. Scalable human organoid arrays like CAMEO are essential for studying disorders that affect speech, cognition, and movement and for testing potential therapies.
- Standardized data-sharing: By making an affordable, easy-to-use hardware standard available, the researchers aim to improve reproducibility and enable straightforward sharing and comparison of electrophysiology data between labs.
Source: North Carolina State University
Overview: The research team has introduced a new class of low-cost, scalable sensors that monitor electrical activity in human cerebral organoids. Electrophysiological recordings are central to understanding brain function; this innovation reduces a major bottleneck in neurodevelopment and genetic disorder research by enabling higher-throughput studies with many more samples.
Human cerebral organoids are millimeter-scale tissues derived from stem cells that contain many of the cell types found across different brain regions. They allow researchers to observe human-specific patterns of neural development and disease processes that animal models cannot faithfully reproduce. Angelman syndrome, for example, is a genetic disorder characterized by developmental delays, intellectual disability, impaired speech, and motor problems—features that are difficult to replicate in nonhuman models. Cerebral organoids provide a human-derived platform to study the underlying genetic mechanisms and to screen therapeutic approaches.
One practical challenge in organoid research is biological variability between samples. To draw reliable conclusions, experiments must include many organoids. Current electrophysiology tools—both 2D and 3D microelectrode arrays—are often expensive, low-throughput, and incompatible with routine organoid culture workflows. Those limitations force many studies to rely on small sample sizes, reducing statistical power and limiting biological insight.
To overcome those obstacles, the authors developed CAMEO, a conformal carbon nanotube microelectrode array that integrates with standard cell culture plates. The array’s twelve nanotube strands form a compliant basket that gently conforms to a spherical organoid, maintaining consistent contact. Each strand’s exposed tip functions as an electrode, transmitting extracellular electrical signals along the nanotube to conventional recording hardware.
In proof-of-concept experiments, CAMEO successfully recorded electrophysiological activity from organoids and detected low-amplitude signals critical to neurodevelopmental studies. The device also registered changes in activity when the organoids were treated with chemicals that modulate neural excitability. Performance matched that of established technologies, while production cost and fabrication complexity were substantially reduced.
The interdisciplinary project combined expertise in electrical engineering, materials science, and neurodevelopmental biology. The team emphasizes that the carbon nanotube electrodes provide favorable electrical, electrochemical, and electromechanical properties at a fraction of the cost of conventional metal electrodes, and they enable a scalable manufacturing route.
By lowering the financial and technical barriers to organoid electrophysiology, CAMEO enables larger sample sizes—tens to hundreds of organoids per study—improving statistical confidence and accelerating the identification of promising therapies. The researchers hope that broad adoption of a standardized, plug-and-play system will facilitate reproducible data sharing across laboratories worldwide.
Funding: Supported by the Foundation for Angelman Syndrome Therapeutics (grant FT2022-02) and the National Science Foundation (grant 2025064).
The lead authors have filed a disclosure to protect intellectual property related to the CAMEO technology.
Key Questions Answered:
A: Rodent brains develop differently from human brains, and many human-specific traits—such as complex speech and higher-order cognition—aren’t captured in animal models. Organoids, derived from human stem cells, provide a closer biological model for studying human neurodevelopment and testing therapies for genetic disorders.
A: Traditional sensors tend to be flat or rigid, which limits contact with three-dimensional tissue. The CAMEO basket conforms to the organoid’s shape so its electrodes maintain gentle, consistent contact, improving signal quality much like cradling a ball in your hand rather than leaving it on a flat surface.
A: Indirectly. By enabling higher-throughput, better-powered experiments, researchers can more quickly identify promising treatments and reduce costly late-stage failures. Testing many organoids per study improves confidence in results and speeds up the preclinical pipeline.
Editorial Notes:
- This article was edited by a Neuroscience News editor.
- Journal paper reviewed in full.
- Additional context added by staff.
About this neurotech research news
Author: Matt Shipman
Source: North Carolina State University
Contact: Matt Shipman – North Carolina State University
Image: The image is credited to Neuroscience News
Original Research: Open access. “Carbon Nanotube Microelectrode Arrays Enable Scalable and Accessible Electrophysiological Recordings of Cerebral Organoids” by Navya Mishra et al., npj Biosensing. DOI: 10.1038/s44328-026-00088-9
Abstract
Carbon Nanotube Microelectrode Arrays Enable Scalable and Accessible Electrophysiological Recordings of Cerebral Organoids
Human cerebral organoids offer a promising platform for studying neurodevelopment, modeling disease, and screening drugs. Electrophysiology is a critical functional readout, but high-throughput electrophysiological studies are limited by cost, low throughput, and incompatibility with standard organoid culture methods. Current 2D and 3D microelectrode arrays are expensive and often impractical for large-scale studies, which restricts adoption and leads to insufficient sample sizes.
This work presents a scalable, low-cost plug-and-play platform that integrates carbon nanotube-based 3D microelectrode arrays into standard cell culture plates, enabling high-throughput extracellular recordings from many organoids without specialized workflows. Using this system, the researchers recorded electrophysiology from 74 human cortical organoids—an unprecedented scale in organoid electrophysiology—and captured phenotypes across neurotypical and Angelman syndrome organoids. Replacing conventional metal electrodes with carbon nanotubes yields improved electrical and mechanical properties at a fraction of the cost and enables scalable manufacturing. This technology establishes a standardized, accessible route to large-scale electrophysiological measurements in cerebral organoids.